Emerging Sub-Segments Transforming the Gouty Arthritis Market Landscape

The gouty arthritis market is on track for significant expansion in the coming years as advances in treatment and growing awareness of the condition drive demand. With more people aging and an increased focus on managing chronic diseases, this sector is set to experience notable growth by 2030. Let's explore the market's size, key players, trends, and important segments shaping its future.

Projected Growth and Market Size of the Gouty Arthritis Market
The gouty arthritis market is forecasted to reach $5.06 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4% during the period. This expansion is largely fueled by an aging global population, greater awareness of chronic diseases, enhanced approaches to preventive arthritis care, improved patient adherence to treatments, and the rise of personalized therapies for gout. Significant trends influencing growth include a rising number of hyperuricemia cases, increasing demand for sustained disease management strategies, the development of combination drug therapies, better adoption of advanced diagnostic imaging techniques, and the growth of lifestyle-focused disease control methods.

Download a free report of the gouty arthritis market report:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Key Factors Accelerating Growth in the Gouty Arthritis Market
One major driver of growth is the increasing prevalence of hyperuricemia, a condition closely linked to gout development. As more patients seek long-term management options, treatments that address both symptoms and underlying causes are gaining traction.
Another important factor is the improved availability and use of diagnostic imaging tools such as ultrasound and dual-energy CT scans, which help in earlier and more accurate detection of gouty arthritis. These advancements enable timely interventions, boosting treatment efficacy and patient outcomes.

Leading Companies Influencing the Gouty Arthritis Market Landscape
Several prominent firms dominate this market, including Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Novartis International AG, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Teijin Pharma Ltd, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, JW Pharmaceutical, Arthrosi Therapeutics Ltd, XORTX Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC, InventisBio Co Ltd, Shanton Pharma, Selecta Biosciences Inc, LG Chem Ltd, and Protalix BioTherapeutics Inc.

View the full gouty arthritis market report:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

In a notable development from October 2023, Amgen Inc., a US-based biotechnology leader, acquired Horizon Therapeutics plc for $27.8 billion. This strategic acquisition aims to bolster Amgen's portfolio in rare diseases and inflammatory conditions, expanding its therapeutic offerings and enhancing revenue potential. Horizon Therapeutics plc, headquartered in Ireland, specializes in treatments specifically targeting gouty arthritis.

Recent Innovations Positively Impacting the Gouty Arthritis Market
Companies within the medical device and healthcare sectors are increasingly focusing on advanced health wearables designed for remote monitoring and personalized wellness management. These smart devices collect continuous biometric data, enabling users to track their health metrics in real time and make informed decisions to maintain wellness.
For example, in May 2025, WHOOP Inc., a US-based medical technology firm, introduced Whoop 5.0 and Whoop MG-next-generation health wearables offering continuous, medical-grade monitoring capabilities. Features include on-demand ECGs, blood pressure tracking, hormonal analysis, and sophisticated recovery insights. These devices operate within a tiered subscription model (Whoop One, Peak, and Life), blending fitness tracking with clinical health assessment to support early detection and proactive health management.

Market Segmentation Highlighting the Leading Gouty Arthritis Categories
The gouty arthritis market is segmented into several key categories:
1) By Type: Acute Gouty Arthritis and Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Relievers, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, and Other Treatments
3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, and Other Diagnostic Methods
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Other Channels
5) By End-User: Hospitals, Specialty Clinics, and Other Users

Further breakdowns within these segments include:
- Acute Gouty Arthritis subtypes such as Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack with intermittent flare-ups, and Severe Acute Gout accompanied by joint deformities.
- Chronic Gouty Arthritis subcategories including Tophaceous Gout (marked by uric acid deposits), Chronic Gout with joint damage, Chronic Gout with renal complications, and Chronic Gout with comorbidities like hypertension and diabetes.

This detailed segmentation allows for targeted treatment development and improved patient care strategies within the gouty arthritis landscape.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.